Cellectis Ownership 2024 | Who Owns Cellectis Now?


OverviewRevenueFinancialsChartTranscripts

Institutional Ownership

2.30%

Insider Ownership

3.87%

Retail Ownership

93.83%

Institutional Holders

11.00

Cellectis Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
LONG FOCUS CAPITAL MANAGEMENT, LLC6.43%0.33%4,617,293130,0002.90%8,634,338Jun 30, 2024
CAPITAL INTERNATIONAL INVESTORS2.57%0.00%1,848,804--3,457,263Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC2.00%0.00%1,438,2551,438,255100.00%2,689,537Jun 30, 2024
BAILLIE GIFFORD & CO0.99%0.00%707,630-119,618-14.46%1,323,268Jun 30, 2024
PRINCIPAL FINANCIAL GROUP INC0.61%0.00%437,00012,4672.94%817,190,000Jun 30, 2024
MACQUARIE GROUP LTD0.32%0.00%226,875--424,000Jun 30, 2024
KBC GROUP NV0.23%0.00%163,447--306,000Jun 30, 2024
LPL FINANCIAL LLC0.13%0.00%91,78710,44012.83%171,642Jun 30, 2024
MORGAN STANLEY0.12%-86,3252,1802.59%161,429Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.06%0.00%40,289-9,591-19.23%75,340Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC0.02%-16,700-100-0.60%31,229Jun 30, 2024
XTX TOPCO LTD0.02%0.00%15,32015,320100.00%28,648Jun 30, 2024
BAIRD FINANCIAL GROUP, INC.0.02%0.00%15,09015,090100.00%28,218Jun 30, 2024
WELLS FARGO & COMPANY/MN0.02%-12,790-150-1.16%23,917Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.01%-10,776--20,151Jun 30, 2024
HARBOUR INVESTMENTS, INC.0.01%0.00%6,100--11,407Jun 30, 2024
RHUMBLINE ADVISERS0.01%-3,855--7,207Jun 30, 2024
NATIONAL BANK OF CANADA /FI/0.01%-3,600--6,884Jun 30, 2024
BLACKROCK INC.0.00%-2,755--5,152Jun 30, 2024
ALLWORTH FINANCIAL LP0.00%-500--1,015Jun 30, 2024

Cellectis's largest institutional shareholder is LONG FOCUS CAPITAL MANAGEMENT, LLC, holding 6.43% of the company's total share outstanding, currently valued at $8.63M. The top 10 institutional shareholders own together 13.45% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
LONG FOCUS CAPITAL MANAGEMENT, LLC6.43%0.33%4,617,293130,0002.90%8,634,338Jun 30, 2024
XTX TOPCO LTD0.02%0.00%15,32015,320100.00%28,648Jun 30, 2024
BAILLIE GIFFORD & CO0.99%0.00%707,630-119,618-14.46%1,323,268Jun 30, 2024
KBC GROUP NV0.23%0.00%163,447--306,000Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC2.00%0.00%1,438,2551,438,255100.00%2,689,537Jun 30, 2024
POM INVESTMENT STRATEGIES, LLC0.00%0.00%495--926Jun 30, 2024
CAPITAL INTERNATIONAL INVESTORS2.57%0.00%1,848,804--3,457,263Jun 30, 2024
MACQUARIE GROUP LTD0.32%0.00%226,875--424,000Jun 30, 2024
PRINCIPAL FINANCIAL GROUP INC0.61%0.00%437,00012,4672.94%817,190,000Jun 30, 2024
HARBOUR INVESTMENTS, INC.0.01%0.00%6,100--11,407Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.06%0.00%40,289-9,591-19.23%75,340Jun 30, 2024
LPL FINANCIAL LLC0.13%0.00%91,78710,44012.83%171,642Jun 30, 2024
BAIRD FINANCIAL GROUP, INC.0.02%0.00%15,09015,090100.00%28,218Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC0.02%-16,700-100-0.60%31,229Jun 30, 2024
MORGAN STANLEY0.12%-86,3252,1802.59%161,429Jun 30, 2024
NATIONAL BANK OF CANADA /FI/0.01%-3,600--6,884Jun 30, 2024
RHUMBLINE ADVISERS0.01%-3,855--7,207Jun 30, 2024
ALLWORTH FINANCIAL LP0.00%-500--1,015Jun 30, 2024
WELLS FARGO & COMPANY/MN0.02%-12,790-150-1.16%23,917Jun 30, 2024
EVERSOURCE WEALTH ADVISORS, LLC--13--29Jun 30, 2024

The largest Cellectis shareholder by % of total assets is LONG FOCUS CAPITAL MANAGEMENT, LLC. The company owns 4.62M shares of Cellectis (CLLS), representing 0.33% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
UBS ASSET MANAGEMENT AMERICAS INC2.00%0.00%1,438,2551,438,255100.00%2,689,537Jun 30, 2024
LONG FOCUS CAPITAL MANAGEMENT, LLC6.43%0.33%4,617,293130,0002.90%8,634,338Jun 30, 2024
XTX TOPCO LTD0.02%0.00%15,32015,320100.00%28,648Jun 30, 2024
BAIRD FINANCIAL GROUP, INC.0.02%0.00%15,09015,090100.00%28,218Jun 30, 2024
PRINCIPAL FINANCIAL GROUP INC0.61%0.00%437,00012,4672.94%817,190,000Jun 30, 2024
LPL FINANCIAL LLC0.13%0.00%91,78710,44012.83%171,642Jun 30, 2024
MORGAN STANLEY0.12%-86,3252,1802.59%161,429Jun 30, 2024
JPMORGAN CHASE & CO0.00%-83--155Jun 30, 2024
TORONTO DOMINION BANK--31--58Jun 30, 2024
BLACKROCK INC.0.00%-2,755--5,152Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.01%-10,776--20,151Jun 30, 2024
EVERSOURCE WEALTH ADVISORS, LLC--13--29Jun 30, 2024
ALLWORTH FINANCIAL LP0.00%-500--1,015Jun 30, 2024
RHUMBLINE ADVISERS0.01%-3,855--7,207Jun 30, 2024
NATIONAL BANK OF CANADA /FI/0.01%-3,600--6,884Jun 30, 2024
HARBOUR INVESTMENTS, INC.0.01%0.00%6,100--11,407Jun 30, 2024
MACQUARIE GROUP LTD0.32%0.00%226,875--424,000Jun 30, 2024
CAPITAL INTERNATIONAL INVESTORS2.57%0.00%1,848,804--3,457,263Jun 30, 2024
POM INVESTMENT STRATEGIES, LLC0.00%0.00%495--926Jun 30, 2024
KBC GROUP NV0.23%0.00%163,447--306,000Jun 30, 2024

As of Jun 30 2024, Cellectis's largest institutional buyer is UBS ASSET MANAGEMENT AMERICAS INC. The company purchased 1.44M stocks of CLLS, valued at $2.69M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
OPPENHEIMER & CO INC----133,890-100.00%-Jun 30, 2024
BAILLIE GIFFORD & CO0.99%0.00%707,630-119,618-14.46%1,323,268Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.06%0.00%40,289-9,591-19.23%75,340Jun 30, 2024
GROUP ONE TRADING, L.P.----1,523-100.00%-Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.----1,080-100.00%-Jun 30, 2024
OLD POINT TRUST & FINANCIAL SERVICES N A----250-100.00%-Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.00%-112-200-64.10%210Jun 30, 2024
WELLS FARGO & COMPANY/MN0.02%-12,790-150-1.16%23,917Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC0.02%-16,700-100-0.60%31,229Jun 30, 2024
FRG FAMILY WEALTH ADVISORS LLC----80-100.00%-Jun 30, 2024
BANK OF AMERICA CORP /DE/--2-34-94.44%4Jun 30, 2024
FINANCIAL GRAVITY ASSET MANAGEMENT, INC.----1-100.00%-Jun 30, 2024
KBC GROUP NV0.23%0.00%163,447--306,000Jun 30, 2024
POM INVESTMENT STRATEGIES, LLC0.00%0.00%495--926Jun 30, 2024
CAPITAL INTERNATIONAL INVESTORS2.57%0.00%1,848,804--3,457,263Jun 30, 2024
MACQUARIE GROUP LTD0.32%0.00%226,875--424,000Jun 30, 2024
HARBOUR INVESTMENTS, INC.0.01%0.00%6,100--11,407Jun 30, 2024
NATIONAL BANK OF CANADA /FI/0.01%-3,600--6,884Jun 30, 2024
RHUMBLINE ADVISERS0.01%-3,855--7,207Jun 30, 2024
ALLWORTH FINANCIAL LP0.00%-500--1,015Jun 30, 2024

As of Jun 30 2024, Cellectis's biggest institutional seller is OPPENHEIMER & CO INC. The company sold -0.13M shares of CLLS, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
UBS ASSET MANAGEMENT AMERICAS INC2.00%0.00%1,438,2551,438,255100.00%2,689,537Jun 30, 2024
XTX TOPCO LTD0.02%0.00%15,32015,320100.00%28,648Jun 30, 2024
BAIRD FINANCIAL GROUP, INC.0.02%0.00%15,09015,090100.00%28,218Jun 30, 2024

Cellectis's largest new institutional shareholder by number of shares is UBS ASSET MANAGEMENT AMERICAS INC, purchased 1.44M shares, valued at $2.69M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
OPPENHEIMER & CO INC----133,890-100.00%-Jun 30, 2024
GROUP ONE TRADING, L.P.----1,523-100.00%-Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.----1,080-100.00%-Jun 30, 2024
OLD POINT TRUST & FINANCIAL SERVICES N A----250-100.00%-Jun 30, 2024
FRG FAMILY WEALTH ADVISORS LLC----80-100.00%-Jun 30, 2024
FINANCIAL GRAVITY ASSET MANAGEMENT, INC.----1-100.00%-Jun 30, 2024

Cellectis's largest sold out institutional shareholder by shares sold is OPPENHEIMER & CO INC, sold -0.13M shares, valued at -, as of undefined.

Cellectis Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
EntrepreneurShares Series Trust0.64%170,547--Dec 31, 2023
Ark ETF Trust0.36%2,898,410--Jan 31, 2024
DELAWARE GROUP EQUITY FUNDS IV0.19%226,875--Mar 28, 2024
TEKLA LIFE SCIENCES INVESTORS0.10%47,437--Mar 31, 2024
EXCHANGE TRADED CONCEPTS TRUST0.06%336,812--Feb 29, 2024
FIDELITY ADVISOR SERIES VII0.04%360,000--Jan 31, 2024
SMALLCAP WORLD FUND INC0.03%1,848,804--Mar 31, 2024
TOCQUEVILLE TRUST0.02%2,500--Jan 31, 2024
EATON VANCE GROWTH TRUST0.02%167,117--Feb 29, 2024
FIDELITY MT VERNON STREET TRUST0.01%419,451--Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND IV0.01%38,393--Mar 31, 2024
Tekla World Healthcare Fund0.01%11,955--Mar 31, 2024
INVESCO BLDRS INDEX FUNDS TRUST0.01%397--Dec 31, 2022
Global X Funds0.00%207,638--Jan 31, 2024
FIDELITY SECURITIES FUND0.00%386,615--Jan 31, 2024
Fidelity Central Investment Portfolios LLC0.00%193,505--Feb 29, 2024
FIDELITY COMMONWEALTH TRUST0.00%8,946--Feb 29, 2024
FIDELITY SELECT PORTFOLIOS0.00%107,465--Feb 29, 2024
BAILLIE GIFFORD FUNDS0.00%10,403--Mar 28, 2024
PRINCIPAL VARIABLE CONTRACTS FUNDS INC0.00%37,100-8,679-18.96%Mar 31, 2024
OLD WESTBURY FUNDS INC0.00%118,061-28,144-19.25%Jan 31, 2024
Advisors' Inner Circle Fund III0.00%16,294--Jan 31, 2024
NORTHERN FUNDS0.00%12,932--Mar 28, 2024
TRUST FOR PROFESSIONAL MANAGERS0.00%21,11813,378172.84%Feb 29, 2024
LAZARD FUNDS INC0.00%2,315--Mar 31, 2024
PRINCIPAL FUNDS, INC.0.00%345,733-20,864-5.69%Jan 31, 2024
FIDELITY CONCORD STREET TRUST0.00%10,776--Feb 29, 2024
USAA MUTUAL FUNDS TRUST0.00%10,154--Jan 31, 2024
Investment Managers Series Trust II0.00%460--Jan 31, 2024
Goldman Sachs ETF Trust0.00%3,272--Feb 29, 2024
LoCorr Investment Trust0.00%671--Mar 31, 2024
PACE SELECT ADVISORS TRUST0.00%7,279--Jan 31, 2024
ETF Series Solutions0.00%475--Jan 31, 2024
VICTORY PORTFOLIOS0.00%660--Mar 31, 2024
iSHARES TRUST0.00%274,920--Mar 31, 2024
Franklin Templeton ETF Trust0.00%1,458--Mar 31, 2024
SPDR SERIES TRUST0.00%263,239--Mar 31, 2024
Blackstone Alternative Investment Funds0.00%400--Mar 31, 2023
PROSHARES TRUST0.00%1,515--Feb 29, 2024
LAZARD RETIREMENT SERIES INC0.00%1,320--Mar 31, 2024
AMERICAN CENTURY ETF TRUST0.00%364--Feb 29, 2024
AMERICAN BEACON FUNDS0.00%12,046--Feb 29, 2024
Invesco Exchange-Traded Fund Trust II0.00%335--Jan 31, 2024
Goldman Sachs Trust II0.00%3,377--Jan 31, 2024
SEI INSTITUTIONAL MANAGED TRUST0.00%998--Dec 31, 2023

Cellectis's largest mutual fund holder by % of total assets is "EntrepreneurShares Series Trust", owning 170.55K shares, compromising 0.64% of its total assets.

Cellectis Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 2411-65.63%
31 Mar, 2432-8.57%
31 Dec, 233512.90%
30 Sep, 2331-8.82%
30 Jun, 233413.33%
31 Mar, 2330-25.00%
31 Dec, 2240-9.09%
30 Sep, 22447.32%
30 Jun, 2241-21.15%
31 Mar, 2252-11.86%
31 Dec, 2159-20.27%
30 Sep, 2174-9.76%
30 Jun, 2182-1.20%
31 Mar, 2183-10.75%
31 Dec, 209325.68%
30 Sep, 2074-7.50%
30 Jun, 208025.00%
31 Mar, 20644.92%
31 Dec, 19611.67%
30 Sep, 1960-16.67%
30 Jun, 197212.50%
31 Mar, 1964-3.03%
31 Dec, 1866-19.51%
30 Sep, 1882-5.75%
30 Jun, 188724.29%
31 Mar, 187012.90%
31 Dec, 176229.17%
30 Sep, 174811.63%
30 Jun, 17432.38%
31 Mar, 174210.53%
31 Dec, 1638-7.32%
30 Sep, 16415.13%
30 Jun, 1639-11.36%
31 Mar, 1644-6.38%
31 Dec, 15479.30%
30 Sep, 15437.50%
30 Jun, 1540-9.09%
31 Mar, 1544-

As of 30 Jun 24, 11 institutions are holding Cellectis's shares, representing a decrease of -65.63% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 241,652,065-83.24%
31 Mar, 249,854,6020.39%
31 Dec, 239,816,725-14.49%
30 Sep, 2311,480,556-18.05%
30 Jun, 2314,008,675-7.05%
31 Mar, 2315,071,85272.57%
31 Dec, 228,733,629-15.22%
30 Sep, 2210,300,913-5.02%
30 Jun, 2210,845,225-11.60%
31 Mar, 2212,268,809-19.22%
31 Dec, 2115,188,388-1.32%
30 Sep, 2115,391,141-5.08%
30 Jun, 2116,214,5766.38%
31 Mar, 2115,242,597-6.59%
31 Dec, 2016,317,91514.74%
30 Sep, 2014,221,8712.26%
30 Jun, 2013,907,451-3.69%
31 Mar, 2014,439,7229.19%
31 Dec, 1913,224,5300.58%
30 Sep, 1913,148,144-2.14%
30 Jun, 1913,435,8395.46%
31 Mar, 1912,740,16410.91%
31 Dec, 1811,487,276-0.19%
30 Sep, 1811,509,6732.15%
30 Jun, 1811,267,37959.78%
31 Mar, 187,051,731-3.51%
31 Dec, 177,308,29624.45%
30 Sep, 175,872,44711.67%
30 Jun, 175,258,929-7.79%
31 Mar, 175,703,1920.58%
31 Dec, 165,670,274-14.59%
30 Sep, 166,638,842-4.24%
30 Jun, 166,932,8647.10%
31 Mar, 166,473,069-8.20%
31 Dec, 157,051,2762.53%
30 Sep, 156,877,6124.19%
30 Jun, 156,601,3287.79%
31 Mar, 156,124,469-

Cellectis (CLLS) has 1.65M shares outstanding as of 30 Jun 24, down -83.24% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 242.30%0.73%
31 Mar, 2417.73%5.68%
31 Dec, 2317.66%4.14%
30 Sep, 2320.65%2.79%
30 Jun, 2327.23%3.17%
31 Mar, 2329.29%7.97%
31 Dec, 2219.17%3.75%
30 Sep, 2222.62%3.98%
30 Jun, 2223.83%3.28%
31 Mar, 2226.97%2.14%
31 Dec, 2135.53%3.10%
30 Sep, 2133.85%2.66%
30 Jun, 2135.67%2.77%
31 Mar, 2135.86%2.44%
31 Dec, 2038.31%3.42%
30 Sep, 2033.47%3.12%
30 Jun, 2032.74%2.83%
31 Mar, 2034.02%3.51%
31 Dec, 1931.15%3.25%
30 Sep, 1930.98%3.09%
30 Jun, 1931.66%3.24%
31 Mar, 1931.25%3.94%
31 Dec, 1828.17%3.83%
30 Sep, 1827.14%3.81%
30 Jun, 1826.69%6.84%
31 Mar, 1819.76%4.71%
31 Dec, 1720.48%7.66%
30 Sep, 1716.35%7.48%
30 Jun, 1714.79%5.68%
31 Mar, 1716.14%6.27%
31 Dec, 1616.05%4.55%
30 Sep, 1618.79%4.87%
30 Jun, 1619.64%5.84%
31 Mar, 1618.34%4.55%
31 Dec, 1520.07%5.23%
30 Sep, 1519.60%5.52%
30 Jun, 1518.84%6.17%
31 Mar, 1517.48%-

As of 30 Jun 24, Cellectis is held by 2.30% institutional shareholders, representing a 0.73% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 242-83.33%
31 Mar, 2412-14.29%
31 Dec, 231427.27%
30 Sep, 231122.22%
30 Jun, 239-40.00%
31 Mar, 2315-6.25%
31 Dec, 2216-15.79%
30 Sep, 221926.67%
30 Jun, 2215-40.00%
31 Mar, 2225-16.67%
31 Dec, 2130-9.09%
30 Sep, 213317.86%
30 Jun, 2128-39.13%
31 Mar, 2146-14.81%
31 Dec, 205492.86%
30 Sep, 2028-41.67%
30 Jun, 204841.18%
31 Mar, 203417.24%
31 Dec, 1929-9.38%
30 Sep, 1932-8.57%
30 Jun, 1935-10.26%
31 Mar, 193925.81%
31 Dec, 1831-26.19%
30 Sep, 1842-23.64%
30 Jun, 185530.95%
31 Mar, 184231.25%
31 Dec, 173239.13%
30 Sep, 172321.05%
30 Jun, 171911.76%
31 Mar, 1717-5.56%
31 Dec, 161812.50%
30 Sep, 1616-11.11%
30 Jun, 1618-
31 Mar, 1618-35.71%
31 Dec, 152840.00%
30 Sep, 1520-25.93%
30 Jun, 1527-38.64%
31 Mar, 1544-

2 institutional shareholders have increased their position in CLLS stock as of 30 Jun 24 compared to 12 in the previous quarter (a -83.33% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 241-80.00%
31 Mar, 245-28.57%
31 Dec, 23716.67%
30 Sep, 236-40.00%
30 Jun, 231042.86%
31 Mar, 237-41.67%
31 Dec, 2212-20.00%
30 Sep, 2215-21.05%
30 Jun, 221926.67%
31 Mar, 2215-11.76%
31 Dec, 2117-15.00%
30 Sep, 2120-41.18%
30 Jun, 213488.89%
31 Mar, 2118-25.00%
31 Dec, 2024-20.00%
30 Sep, 203036.36%
30 Jun, 202229.41%
31 Mar, 2017-
31 Dec, 191713.33%
30 Sep, 1915-37.50%
30 Jun, 192471.43%
31 Mar, 1914-33.33%
31 Dec, 182110.53%
30 Sep, 181946.15%
30 Jun, 1813-7.14%
31 Mar, 181440.00%
31 Dec, 171011.11%
30 Sep, 179-18.18%
30 Jun, 171122.22%
31 Mar, 179-
31 Dec, 169-10.00%
30 Sep, 161011.11%
30 Jun, 169-30.77%
31 Mar, 161318.18%
31 Dec, 151110.00%
30 Sep, 151066.67%
30 Jun, 156-
31 Mar, 15--

1 institutional shareholders have reduced their position in CLLS stock as of 30 Jun 24 compared to 5 in the previous quarter (a -80.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 2411-65.63%1,652,065-83.24%2.30%0.73%2-83.33%1-80.00%
31 Mar, 2432-8.57%9,854,6020.39%17.73%5.68%12-14.29%5-28.57%
31 Dec, 233512.90%9,816,725-14.49%17.66%4.14%1427.27%716.67%
30 Sep, 2331-8.82%11,480,556-18.05%20.65%2.79%1122.22%6-40.00%
30 Jun, 233413.33%14,008,675-7.05%27.23%3.17%9-40.00%1042.86%
31 Mar, 2330-25.00%15,071,85272.57%29.29%7.97%15-6.25%7-41.67%
31 Dec, 2240-9.09%8,733,629-15.22%19.17%3.75%16-15.79%12-20.00%
30 Sep, 22447.32%10,300,913-5.02%22.62%3.98%1926.67%15-21.05%
30 Jun, 2241-21.15%10,845,225-11.60%23.83%3.28%15-40.00%1926.67%
31 Mar, 2252-11.86%12,268,809-19.22%26.97%2.14%25-16.67%15-11.76%
31 Dec, 2159-20.27%15,188,388-1.32%35.53%3.10%30-9.09%17-15.00%
30 Sep, 2174-9.76%15,391,141-5.08%33.85%2.66%3317.86%20-41.18%
30 Jun, 2182-1.20%16,214,5766.38%35.67%2.77%28-39.13%3488.89%
31 Mar, 2183-10.75%15,242,597-6.59%35.86%2.44%46-14.81%18-25.00%
31 Dec, 209325.68%16,317,91514.74%38.31%3.42%5492.86%24-20.00%
30 Sep, 2074-7.50%14,221,8712.26%33.47%3.12%28-41.67%3036.36%
30 Jun, 208025.00%13,907,451-3.69%32.74%2.83%4841.18%2229.41%
31 Mar, 20644.92%14,439,7229.19%34.02%3.51%3417.24%17-
31 Dec, 19611.67%13,224,5300.58%31.15%3.25%29-9.38%1713.33%
30 Sep, 1960-16.67%13,148,144-2.14%30.98%3.09%32-8.57%15-37.50%
30 Jun, 197212.50%13,435,8395.46%31.66%3.24%35-10.26%2471.43%
31 Mar, 1964-3.03%12,740,16410.91%31.25%3.94%3925.81%14-33.33%
31 Dec, 1866-19.51%11,487,276-0.19%28.17%3.83%31-26.19%2110.53%
30 Sep, 1882-5.75%11,509,6732.15%27.14%3.81%42-23.64%1946.15%
30 Jun, 188724.29%11,267,37959.78%26.69%6.84%5530.95%13-7.14%
31 Mar, 187012.90%7,051,731-3.51%19.76%4.71%4231.25%1440.00%
31 Dec, 176229.17%7,308,29624.45%20.48%7.66%3239.13%1011.11%
30 Sep, 174811.63%5,872,44711.67%16.35%7.48%2321.05%9-18.18%
30 Jun, 17432.38%5,258,929-7.79%14.79%5.68%1911.76%1122.22%
31 Mar, 174210.53%5,703,1920.58%16.14%6.27%17-5.56%9-
31 Dec, 1638-7.32%5,670,274-14.59%16.05%4.55%1812.50%9-10.00%
30 Sep, 16415.13%6,638,842-4.24%18.79%4.87%16-11.11%1011.11%
30 Jun, 1639-11.36%6,932,8647.10%19.64%5.84%18-9-30.77%
31 Mar, 1644-6.38%6,473,069-8.20%18.34%4.55%18-35.71%1318.18%
31 Dec, 15479.30%7,051,2762.53%20.07%5.23%2840.00%1110.00%
30 Sep, 15437.50%6,877,6124.19%19.60%5.52%20-25.93%1066.67%
30 Jun, 1540-9.09%6,601,3287.79%18.84%6.17%27-38.64%6-
31 Mar, 1544-6,124,469-17.48%-44---

Cellectis Peer Ownership


TickerCompany
SLNOSoleno Therapeutics, Inc.
NRIXNurix Therapeutics, Inc.
CYTCyteir Therapeutics, Inc.
KYMRKymera Therapeutics, Inc.
FHTXFoghorn Therapeutics Inc.
INBXInhibrx Biosciences, Inc.
RGNXREGENXBIO Inc.
LIANLianBio
ERYPPHAXIAM Therapeutics S.A.
SGTXSigilon Therapeutics, Inc.
PASGPassage Bio, Inc.
IPHAInnate Pharma S.A.
CRNXCrinetics Pharmaceuticals, Inc.
HCWBHCW Biologics Inc.
GLUEMonte Rosa Therapeutics, Inc.
DMACDiaMedica Therapeutics Inc.
ANEBAnebulo Pharmaceuticals, Inc.
GNFTGenfit S.A.
KZRKezar Life Sciences, Inc.
STTKShattuck Labs, Inc.
ELYMEliem Therapeutics, Inc.

CLLS Ownership FAQ


Cellectis is owned by institutional shareholders (2.30%), insiders (3.87%), and public (93.83%). The largest institutional shareholder of Cellectis is LONG FOCUS CAPITAL MANAGEMENT, LLC (6.43% of total shares) and the top mutual fund owner is EntrepreneurShares Series Trust (0.64% of total shares).

Cellectis's major institutional shareholders are LONG FOCUS CAPITAL MANAGEMENT, LLC, CAPITAL INTERNATIONAL INVESTORS, UBS ASSET MANAGEMENT AMERICAS INC, BAILLIE GIFFORD & CO, and PRINCIPAL FINANCIAL GROUP INC. The top five shareholders own together 12.60% of the company's share outstanding.

As of Jun 2024, there are 11 institutional shareholders of Cellectis.

LONG FOCUS CAPITAL MANAGEMENT, LLC owns 4.62M shares of Cellectis, representing 6.43% of the company's total shares outstanding, valued at $8.63M (as of Jun 2024).

As of Jun 2024, CAPITAL INTERNATIONAL INVESTORS holds 1.85M shares of Cellectis (CLLS), compromising 2.57% of the company, valued at $3.46M.

UBS ASSET MANAGEMENT AMERICAS INC is the third largest holder of Cellectis. The company owns 1.44M of the company's shares outstanding (worth $2.69M).